GlassScriptPhysician profile
James Pimentel
NPI 1265046379
$1,420.98
in general payments reported to CMS, 2019-2025
18 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $23.53 · 2022: $121 · 2023: $434 · 2024: $386 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,276.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $260.92 | 2022-2025 | Veklury |
| Alexion Pharmaceuticals, INC. | $190.27 | 2022-2023 | Ultomiris |
| La Jolla Pharmaceutical Company | $166.78 | 2024-2025 | Giapreza |
| Madrigal Pharmaceuticals | $142.13 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $139.29 | 2025 | Iqirvo |
| Shionogi INC | $124.70 | 2023 | Fetroja |
| Astrazeneca Pharmaceuticals LP | $70.55 | 2023-2024 | Andexxa |
| Abbvie INC. | $55.21 | 2023-2025 | |
| Teleflex LLC | $47.97 | 2023-2024 | Arrow |
| Inari Medical, INC. | $43.45 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Melinta Therapeutics, LLC | $42.21 | 2022-2023 | Kimyrsa, Rezzayo, Vabomere |
| Janssen Pharmaceuticals, INC | $42.18 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $19.13 | 2022 | |
| Mylan Specialty L.P. | $18.18 | 2022 | |
| Csl Behring | $17.98 | 2023 | Kcentra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.21 | 2023 | Recarbrio, Zerbaxa |
| Chiesi USA, INC. | $13.96 | 2024 | Cleviprex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Pimentel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.